(Reuters) – Elon Musk’s brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration’s “breakthrough device” designation.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.